Adding Value in the Postanalytical Phase.
Apart from maintaining the highest quality of analytical test results, laboratories are now getting more focused on how to achieve the greatest impact of laboratory results on their patient's outcome. Laboratory professionals are now in the learning phase of implementing new practices at different steps of the extra-analytical phases of the testing process where laboratories used to contribute seldom, only sporadically. Recently, the achievable levels of harmonization and responsible contributors at various steps of the testing process have also been proposed. Based on this proposal some tasks of the extra-analytical phase should become primarily the responsibility of laboratories with the involvement of clinicians, like additive testing, individualized interpretative commenting and reporting results with clinical urgency in postanalytical (PA) phase. These tasks can be good targets to start with or to increase patient outcome-oriented extra-analytical activities of laboratories. The status of the present practice of the PA activities for which laboratories proposed to be primarily responsible in the testing process - laboratory-driven PA tasks - will be reviewed below. In addition, approaches of quality assessment (QA) with quality specifications of these laboratory-driven PA tasks and the available best practice recommendations in the light of the achievable level of harmonization will be discussed. Laboratory professionals are encouraged to improve their methodological, theoretical and communicational skills and take the lead and participate in the discussed PA activities that can assist in translating laboratory test results into clinical meaning and thereby lead to better clinical utilization of laboratory test results.
Central Laboratory, Jósa András University Hospital , Nyíregyháza, Hungary.
Éva
É
Ajzner
added-value; clinical interpretation; critical-risk result; outcome-driven testing; postanalytical phase; reflective testing; reflex testing; significant-risk result reporting; test utilization
Implement Sci. 2015 Dec 05;10:167
26637335
J Multidiscip Healthc. 2012;5:277-87
23152686
Ann Clin Biochem. 2008 Jan;45(Pt 1):88-90
18275680
Clin Chem. 2004 Mar;50(3):632-7
14981029
Clin Chem. 2000 Aug;46(8 Pt 1):1041-50
10926881
Arch Pathol Lab Med. 2004 Dec;128(12):1424-7
15578888
Clin Biochem Rev. 2004;25(4):207-15
18458714
Clin Chem. 2012 Dec;58(12):1636-43
22730450
Clin Chim Acta. 2009 Jun;404(1):46-51
19298798
Am J Clin Pathol. 2014 Jun;141(6):767-9
24838317
Am J Clin Pathol. 2011 Dec;136(6):829-33
22095366
Clin Chem. 1995 Aug;41(8 Pt 2):1256-62
7628116
Clin Chem. 2014 Dec;60(12):1569-70
25189694
Clin Chim Acta. 2014 May 15;432:135-47
24246790
Clin Chem. 2004 Mar;50(3):471-2
14981026
Clin Biochem Rev. 2012 Nov;33(4):149-60
23267247
Ann Clin Biochem. 2010 May;47(Pt 3):223-7
20392754
Ann Intern Med. 2004 Aug 3;141(3):196-204
15289216
Clin Chem Lab Med. 2016 Jul 1;54(7):1169-76
26656613
Clin Chem Lab Med. 2014 Jul;52(7):951-8
24622792
Clin Chem Lab Med. 2013 Apr;51(4):741-51
23435100
Scand J Clin Lab Invest. 2012 Apr;72(2):143-51
22214324
Clin Chem Lab Med. 2015 Sep 1;53(10):1593-603
26023801
Clin Chem Lab Med. 2007;45(6):712-9
17579522
BMJ. 2012 Mar 20;344:e1169
22434088
Clin Biochem Rev. 2012 Aug;33(3):81-4
22930601
Int J Med Inform. 2013 May;82(5):345-58
23273628
Clin Chim Acta. 2014 May 15;432:8-14
24326129
Clin Chem Lab Med. 2013 Jan;51(1):221-7
23079513
Clin Chem Lab Med. 2012 Apr 28;50(7):1249-52
22850057
BMJ Qual Saf. 2013 Oct;22 Suppl 2:ii6-ii10
23955467